IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

Bacteria: Prospective Savior in Battle against Cancer. N. NAIR, T. KASAI, M. SENO (Okayama, Japan). Anticancer Res 34: 6289-6296. 2014
Surgical Management of Microscopic Positive Resection Margin After Gastrectomy for Gastric Cancer: A Systematic Review of Gastric R1 Management. P. AURELLO, P. MAGISTRI, G. NIGRI, N. PETRUCCIANI, L. NOVI, L. ANTOLINO, F. D’ANGELO, G. RAMACCIATO (Rome, Italy). Anticancer Res 34: 6283-6288. 2014
Current Concepts in Colorectal Cancer Prevention with Cyclooxygenase Inhibitors. G. SINGH RANGER (Waterville, New Brunswick; Halifax, Nova Scotia, Canada). Anticancer Res 34: 6277-6286. 2014
Surgery for Symptomatic Colon Lipoma: A Systematic Review of the Literature. D. CROCETTI, P. SAPIENZA, A.V. STERPETTI, A. PALIOTTA, A. DE GORI, G. PEDULLÀ, G. DE TOMA (Rome, Italy). Anticancer Res 34: 6271-6276. 2014
Resistance to Abiraterone in Castration-resistant Prostate Cancer: A Review of the Literature. S. GIACINTI, M. BASSANELLI, A.M. ASCHELTER, A. MILANO, M. ROBERTO, P. MARCHETTI (Rome, Italy). Anticancer Res 34: 6265-6269. 2014
NOTCH Signaling Roles in Acute Myeloid Leukemia Cell Growth and Interaction with other Stemnessrelated Signals. S. TOHDA (Tokyo, Japan). Anticancer Res 34: 6259-6264. 2014
Chemotherapy of Rare Skin Adnexal Tumors: A Review of Literature. F.DE IULIIS, L. AMOROSO, L. TAGLIERI, S. VENDITTOZZI, L. BLASI, G. SALERNO, R. LANZA, S. SCARPA (Rome, Italy). Anticancer Res 34: 5263-5268. 2014
Soft Tissue Limb and Trunk Sarcomas: Diagnosis, Treatment and Follow-up. M. RASTRELLI, S. TROPEA, U. BASSO, A. ROMA, M. MARUZZO, C.R. ROSSI (Padova, Italy). Anticancer Res 34: 5251-5262. 2014
Pharmacogenomics in Lung Cancer Chemotherapy: A Review of What the Oncologist Should Know. C.D’ANTONIO, A. MILANO, R. RIGHINI, C.E. ONESTI, M. BASSANELLI, R. FALCONE, I. PARIS, S. LAURO, P. MARCHETTI (Rome, Italy). Anticancer Res 34: 5241-5250. 2014
Genes Associated with Succeptibility to Lung Adenocarcinoma Among Never Smokers Suggest the Mechanism of Disease. I. OKAZAKI, S. ISHIKAWA, Y. SOHARA (Tokyo; Otawara, Tochigi, Japan). Anticancer Res 34: 5229-5240. 2014
Neoadjuvant Strategy as Initial Treatment in Resectable Pancreatic Cancer: Concrete Evidence of Benefit. F. DE FELICE, D. MUSIO, N. RAFFETTO, V. TOMBOLINI (Rome, Italy). Anticancer Res 34: 4673-4676. 2014
The Intercellular Cell Adhesion Molecule-1 (ICAM-1) in Lung Cancer: Implications for Disease Progression and Prognosis. E.A. KOTTEAS, P. BOULAS, I. GKIOZOS, S. TSAGKOULI, G. TSOUKALA, K.N. SYRIGOS (Athens, Greece). Anticancer Res 34: 4665-4672. 2014
Sono-Photodynamic Combination Therapy: A Review on Sensitizers. K.C. SADANALA, P.K. CHATURVEDI, Y.M. SEO, J.M. KIM, Y.S. JO, Y.K. LEE, W.S. AHN (Seoul, South Korea). Anticancer Res 34: 4657-4664. 2014
Factors Associated with Radiosensitivity of Cervical Cancer. C. QIN, X. CHEN, Q. BAI, M.R. DAVIS, Y. FANG (Shenzhen, P.R. China; Des Moines, IA; Columbia, MO, USA). Anticancer Res 34: 4649-4656. 2014
Vitamin D and Cardiovascular Disease. A. ZITTERMANN (Bad Oeynhausen, Germany). Anticancer Res 34: 4641-4648. 2014
The RECK Gene and Biological Malignancy–Its Significance in Angiogenesis and Inhibition of Matrix Metalloproteinases. M. ALEXIUS-LINDGREN, E. ANDERSSON, I. LINDSTEDT, W. ENGSTRÖM (Uppsala, Sweden). Anticancer Res 34: 3867-3873. 2014
Erdheim-Chester Disease: A Comprehensive Review. A.M. ABDELFATTAH, K. ARNAOUT, I.A. TABBARA (Washington, DC, USA; Alexandria, Egypt). Anticancer Res 34: 3257-3261. 2014
Regulation and Involvement in Cancer and Pathological Conditions of MAGI1, a Tight Junction Protein. X. FENG, S. JIA, T.A. MARTIN, W.G. JIANG (Hohhot, PR China; Cardiff, UK). Anticancer Res 34: 3251-3256. 2014
Cardiotoxicity of Molecular- targeted Drug Therapy. D.L. LE, H. CAO, L.-X. YANG (San Francisco, CA, USA). Anticancer Res 34: 3243-3249. 2014
MicroRNAs in Testicular Cancer: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy. A. BEZAN, A. GERGER, M. PICHLER (Graz, Austria; Houston, TX, USA). Anticancer Res 34: 2709-2713. 2014
Vascularized Bone Graft for Oncological Reconstruction of the Extremities: Review of the Biological Advantages. K. MURAMATSU, T. HASHIMOTO, Y. TOMINAGA. T. TAGUCHI (Ube, Yamaguchi, Japan). Anticancer Res 34: 2701-2707. 2014
Inefficacy of Therapeutic Cancer Vaccines and Proposed Improvements. Casus of Prostate Cancer. J.J. L. JACOBS, C. SNACKEY, A.A. GELDOF, D. CHARACIEJUS, R.J.A. VAN MOORSELAAR, W. DEN OTTER (Amsterdam; Haarlem, Netherlands; Vilnius, Lithuania). Anticancer Res 34: 2689-2700. 2014
Gastrectomy for Stage IV Gastric Cancer. A Systematic Review and Meta-analysis. K. LASITHIOTAKIS, S.A. ANTONIOU, G.A. ANTONIOU, I. KAKLAMANOS, O. ZORAS (Heraklion; Athens, Greece; Newcastle upon Tyne, UK). Anticancer Res 34: 2087-2094. 2014
Gastrectomy for Stage IV Gastric Cancer. A Systematic Review and Meta-analysis. K. LASITHIOTAKIS, S.A. ANTONIOU, G.A. ANTONIOU, I. KAKLAMANOS, O. ZORAS (Heraklion; Athens, Greece; Newcastle upon Tyne, UK). Anticancer Res 34: 2077-2085. 2014
Advanced Epithelial Ovarian Cancer: From Standard Chemotherapy to Promising Molecular Pathway Targets – Where Are we Now? J. SYRIOS, S. BANERJEE, S.B. KAYE (London, UK). Anticancer Res 34: 2069-2077. 2014
Molecular Biomarkers and Classification Models in the Evaluation of the Prognosis of Colorectal Cancer. M. SIDERIS, S. PAPAGRIGORIADIS (London, UK). Anticancer Res 34: 2061-2068. 2014
Targeting Tropomyosin-receptor Kinase Fused Gene in Cancer. Y. CHEN, S.-H. TSENG (New Taipei; Taoyuan; Taipei, Taiwan, ROC). Anticancer Res 34: 1591-1600. 2014
New Treatment Paradigm for Patients with Anaplastic Oligodendroglial Tumors. J. POLIVKA JR., J. POLIVKA, V. ROHAN, O. TOPOLCAN (Plzen, Czech Republic). Anticancer Res 34: 1587-1594. 2014
Subcutaneous Administration of Anticancer Agents. D. LEVEQUE (Strasbourg, France). Anticancer Res 34: 1579-1586. 2014
Malignant Ascites in Ovarian Cancer and the Role of Targeted Therapeutics. E. SMOLLE, V. TAUCHER, J. HAYBAECK (Graz, Austria). Anticancer Res 34: 1553-1561. 2014
New Possibilities in Hepatocellular Carcinoma Treatment. M. RASOOL, S. RASHID, M. AROOJ, S.A. ANSARI, K.M. KHAN, A. MALIK, M.I. NASEER, S. ZAHID, A. MANAN, M. ASIF, Z. RAZZAQ, S. ASHRAF, M.H. QAZI, Z. IQBAL, S.H. GAN, M.A. KAMAL, I.A. SHEIKH (Jeddah; Riyadh, Saudi Arabia; Lahore; Quetta, Pakistan; Kelantan, Malaysia). Anticancer Res 34: 1563-1571. 2014
New Anticancer Agents: Role of Clinical Pharmacy Services. D. LEVEQUE, A. DELPEUCH, B, GOURIEUX (Strasbourg, France). Anticancer Res 34: 1519-1530. 2014
Treatment of Acute Promyelocytic Leukemia. E. ELBAHESH, N. PATEL, I.A. TABBARA (Washington, DC, USA). Anticancer Res 34: 1507-1517. 2014
New Developments in the Treatment of Metastatic Melanoma: Immune Checkpoint Inhibitors and Targeted Therapies. K. AZIJLI, E. STELLOO, G.J. PETERS, A.J.M. VAN DEN EERTWEGH (Amsterdam, Netherlands). Anticancer Res 34: 1493-1505. 2014
Pertuzumab: Development Beyond Breast Cancer. P. BARTHÉLÉMY, J. LEBLANC, V. GOLDBARG, F. WENDLING, J.-E. KURTZ (Strasbourg, France). Anticancer Res 34: 1483-1491. 2014
Targeting Extracellular ROS Signaling of Tumor Cells. G. BAUER (Freiburg, Germany). Anticancer Res 34: 1467-1482. 2014
Family of Peptides Synthesized in the Human Body Have Anticancer Effects. D.L. VESELY (Tampa, FL, USA). Anticancer Res 34: 1459-1466. 2014
Endothelial Dysfunction as a Determinant of Trastuzumab-mediated Cardiotoxicity in Patients with Breast Cancer. A. SANDOO, G.D. KITAS, A.R. CARMICHAEL (Dudley, West Midlands, UK). Anticancer Res 34: 1147-1151. 2014
The Management of Screen-detected Breast Cancer. M. AHMED, M. DOUEK (London, UK). Anticancer Res 34: 1141-1146. 2014
Mapping Oxidative Changes in Breast Cancer: Understanding the Basic to Reach the Clinics. A. MENCALHA, V.J. VICTORINO, R. CECCHINI, C. PANIS (Rio de Janeiro; São Paulo; Londrina, Brazil). Anticancer Res 34: 1127-1140. 2014
Predictive and Prognostic Significance of Tumor-infiltrating Lymphocytes in Patients with Breast Cancer Treated with Neoadjuvant Systemic Therapy. B. MELICHAR, H. ŠTUDENTOVÁ, H. KALÁBOVÁ, D. VITÁSKOVÁ, P. ČERMÁKOVÁ, H. HORNYCHOVÁ, A. RYŠKA (Olomouc; Hradec Králové, Czech Republic). Anticancer Res 34: 1115-1125. 2014
Current Approaches to Managing Partial Breast Defects: The Role of Conservative Breast Surgery Reconstruction. A.M. MUNHOZ, E. MONTAG, J.R. FILASSI, R. GEMPERLI (São Paulo, Brazil). Anticancer Res 34: 1099-1114. 2014
Clinical Utility of Ultrasound-Needle Biopsy for Preoperative Staging of the Axilla in Invasive Breast Cancer. N. HOUSSAMI, S.C.E. DIEPSTRATEN, H.S. CODY III, R.M. TURNER, A.R. SEVER (Sydney, NSW, Australia; Utrecht, Netherlands; New York, NY, USA; Maidstone, UK). Anticancer Res 34: 1087-1097. 2014
Glycodelin A – A Famous Lipocalin and its Role in Breast Cancer. A.C. KÖLBL, U. JESCHKE, D. DIAN, K. FRIESE, U. ANDERGASSEN (Munich, Germany). Anticancer Res 34: 1079-1085. 2014
Genetic and Epigenetic Aspects of Breast Cancer Progression and Therapy. S. BYLER, S. GOLDGAR, S. HEERBOTH, M. LEARY, G. HOUSMAN, K. MOULTON, S. SARKAR (Boston, MA, USA).Anticancer Res 34: 1071-1077. 2014
Hypoxic Condition and Prognosis in Oral Squamous Cell Carcinoma. P.O. DE LIMA, C.C. JORGE, D.T. OLIVEIRA, M.C. PEREIRA (Divinópolis, Minas Gerais; Bauru, São Paulo, Brazil). Anticancer Res 34: 605-612. 2014
Histidine Rich Glycoprotein and Cancer: A Multi-faceted Relationship. L.D.S. JOHNSON, H.A. GOUBRAN, R.R. KOTB (Victoria; Vancouver, BC; Saskatoon, SK, Canada). Anticancer Res 34: 593-603. 2014
Application of FDG-PET in Cervical Cancer and Endometrial Cancer: Utility and Future Prospects. Y. NOGAMI, M. IIDA, K. BANNO, I. KISU, M. ADACHI, K. NAKAMURA, K. UMENE, K. MASUDA, E. TOMINAGA, K. TANAKA, D. AOKI (Tokyo, Japan). Anticancer Res 34: 585-592. 2014
Chemoembolization in Colorectal Liver Metastases: The Rebirth. G. FIORENTINI, C. ALIBERTI, L. MULAZZANI, P. COSCHIERA, V. CATALANO, D. ROSSI, P. GIORDANI, S. RICCI (Pesaro; Padova; Ancona, Italy). Anticancer Res 34: 575-584. 2014
Fighting Fire with Fire: The Revival of Thermotherapy for Gliomas. W.L. TITSWORTH, G.J.A. MURAD, B.L. HOH, M. RAHMAN (Gainesville, FL, USA). Anticancer Res 34: 565-574. 2014
Page: 1 2 3 4 5 6 ... 7 8 9 10 11 12 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system